Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1966 2
1967 1
1968 2
1973 3
1975 2
1976 1
1977 1
1979 3
1980 3
1981 3
1982 3
1983 4
1984 5
1985 2
1986 5
1987 3
1988 4
1989 10
1990 8
1991 8
1992 9
1993 19
1994 15
1995 18
1996 29
1997 28
1998 28
1999 29
2000 35
2001 31
2002 52
2003 62
2004 91
2005 116
2006 115
2007 150
2008 173
2009 217
2010 245
2011 279
2012 338
2013 421
2014 541
2015 558
2016 560
2017 653
2018 712
2019 842
2020 989
2021 1150
2022 1357
2023 1036
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

9,889 results

Results by year

Filters applied: . Clear all
Page 1
Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection.
Wang H, Liu C, Xie X, Niu M, Wang Y, Cheng X, Zhang B, Zhang D, Liu M, Sun R, Ma Y, Ma S, Wang H, Zhu G, Lu Y, Huang B, Su P, Chen X, Zhao J, Wang H, Shen L, Fu L, Huang Q, Yang Y, Wang H, Wu C, Ge W, Chen C, Huo Q, Wang Q, Wang Y, Geng L, Xie Y, Xie Y, Liu L, Qi J, Chen H, Wu J, Jiang E, Jiang W, Wang X, Shen Z, Guo T, Zhou J, Zhu P, Cheng T. Wang H, et al. Among authors: shen l. Immunity. 2023 Jun 13;56(6):1410-1428.e8. doi: 10.1016/j.immuni.2023.05.007. Epub 2023 May 16. Immunity. 2023. PMID: 37257450 Free PMC article.
Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man.
Lopera F, Marino C, Chandrahas AS, O'Hare M, Villalba-Moreno ND, Aguillon D, Baena A, Sanchez JS, Vila-Castelar C, Ramirez Gomez L, Chmielewska N, Oliveira GM, Littau JL, Hartmann K, Park K, Krasemann S, Glatzel M, Schoemaker D, Gonzalez-Buendia L, Delgado-Tirado S, Arevalo-Alquichire S, Saez-Torres KL, Amarnani D, Kim LA, Mazzarino RC, Gordon H, Bocanegra Y, Villegas A, Gai X, Bootwalla M, Ji J, Shen L, Kosik KS, Su Y, Chen Y, Schultz A, Sperling RA, Johnson K, Reiman EM, Sepulveda-Falla D, Arboleda-Velasquez JF, Quiroz YT. Lopera F, et al. Among authors: shen l. Nat Med. 2023 May;29(5):1243-1252. doi: 10.1038/s41591-023-02318-3. Epub 2023 May 15. Nat Med. 2023. PMID: 37188781 Free PMC article.
Ferromagnetic transition-metal dopedɛ-phosphorene.
Wang Z, Wu Q, Shen L. Wang Z, et al. Among authors: shen l. J Phys Condens Matter. 2023 Jul 13;35(41). doi: 10.1088/1361-648X/ace40f. J Phys Condens Matter. 2023. PMID: 37402378
Far-infrared transparent conductors.
Hu C, Zhou Z, Zhang X, Guo K, Cui C, Li Y, Gu Z, Zhang W, Shen L, Zhu J. Hu C, et al. Among authors: shen l. Light Sci Appl. 2023 Apr 21;12(1):98. doi: 10.1038/s41377-023-01139-w. Light Sci Appl. 2023. PMID: 37085484 Free PMC article.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study.
Xu J, Kato K, Raymond E, Hubner RA, Shu Y, Pan Y, Park SR, Ping L, Jiang Y, Zhang J, Wu X, Yao Y, Shen L, Kojima T, Gotovkin E, Ishihara R, Wyrwicz L, Van Cutsem E, Jimenez-Fonseca P, Lin CY, Wang L, Shi J, Li L, Yoon HH. Xu J, et al. Among authors: shen l. Lancet Oncol. 2023 May;24(5):483-495. doi: 10.1016/S1470-2045(23)00108-0. Epub 2023 Apr 17. Lancet Oncol. 2023. PMID: 37080222 Clinical Trial.
Quantum Imitation Learning.
Cheng Z, Zhang K, Shen L, Tao D. Cheng Z, et al. Among authors: shen l. IEEE Trans Neural Netw Learn Syst. 2023 May 29;PP. doi: 10.1109/TNNLS.2023.3275075. Online ahead of print. IEEE Trans Neural Netw Learn Syst. 2023. PMID: 37247311
Biomaterials evolution: from inert to instructive.
Iqbal S, Sohail M, Fang S, Ding J, Shen L, Chen M, Shu G, Du YZ, Ji J. Iqbal S, et al. Among authors: shen l. Biomater Sci. 2023 Sep 12;11(18):6109-6115. doi: 10.1039/d3bm00322a. Biomater Sci. 2023. PMID: 37591802 Review.
New treatment for osteoarthritis: Gene therapy.
Li X, Shen L, Deng Z, Huang Z. Li X, et al. Among authors: shen l. Precis Clin Med. 2023 May 30;6(2):pbad014. doi: 10.1093/pcmedi/pbad014. eCollection 2023 Jun. Precis Clin Med. 2023. PMID: 37333626 Free PMC article. Review.
Superscattering of water waves.
Qin Z, Qian C, Shen L, Wang X, Kaminer I, Chen H, Wang H. Qin Z, et al. Among authors: shen l. Natl Sci Rev. 2022 Nov 10;10(7):nwac255. doi: 10.1093/nsr/nwac255. eCollection 2023 Jul. Natl Sci Rev. 2022. PMID: 37266547 Free PMC article.
Managing osteoporosis in COPD.
Shen L, Lv J, Li J, Zhou J, Wang X. Shen L, et al. Endocr Metab Immune Disord Drug Targets. 2023 Sep 13. doi: 10.2174/1871530323666230913105752. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37711118
9,889 results